SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-19-050033
Filing Date
2019-02-25
Accepted
2019-02-25 17:08:32
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC14D9C d703710dsc14d9c.htm SC14D9C 13930
2 EX-99.1 d703710dex991.htm EX-99.1 878
3 EX-99.2 d703710dex992.htm EX-99.2 1194
4 GRAPHIC g7037102.jpg GRAPHIC 53228
5 GRAPHIC g703710n1.jpg GRAPHIC 65508
  Complete submission text file 0001193125-19-050033.txt   181335
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filed by) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Subject) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-88577 | Film No.: 19630412
SIC: 2836 Biological Products, (No Diagnostic Substances)